Combined modality therapy including cytoreductive surgery and heated intraperitoneal chemotherapy for synchronous low volume peritoneal carcinomatosis from adenocarcinoma of the tail of pancreas in a BRCA-2 carrier resulting in long-term disease-free survival: A case report. [PDF]
Int J Surg Case Rep, 2021 Hoefer RA +4 more
europepmc +1 more source
Optimal switching strategies in multi-drug therapies for chronic diseases [PDF]
arXivAntimicrobial resistance is a threat to public health with millions of deaths linked to drug resistant infections every year. To mitigate resistance, common strategies that are used are combination therapies and therapy switching. However, the stochastic nature of pathogenic mutation makes the optimization of these strategies challenging.
arxiv
The estimation of preoperative combined modality therapy for liver carcinoma.
, 1987 Minoru Nakamoto +5 more
openalex +2 more sources
Combined modality treatment of high-risk T1 bladder cancer: More effective than intravesical therapy, less radical than cystectomy [PDF]
, 2004 Christian Weiß +3 more
openalex +1 more source
A1-03: Rethinking prognostic factors in the era of combined modality therapy for Locally Advanced Non-small Cell Lung Cancer (LA-NSCLC): a retrospective analysis of RTOG Protocols 9410 and 9801 [PDF]
, 2007 Corey J. Langer +7 more
openalex +1 more source
Partial omission of bleomycin for early-stage Hodgkin lymphoma patients treated with combined modality therapy: Does incomplete ABVD lead to inferior outcomes? [PDF]
EJHaem, 2020 Gunther JR +12 more
europepmc +1 more source
A5-02: Targeted therapy against VEGFR and/or EGFR signaling with AZD2171, vandetanib, and gefitinib as part of a combined modality approach for the treatment of non-small-cell lung cancer [PDF]
, 2007 Michael S. O’Reilly +7 more
openalex +1 more source